The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 12,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Learn more at ARVO.org
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents. Our Woodstock, IL facility is an ophthalmic center-of-excellence for advanced aseptic Blow-Fill-Seal (BFS) manufacturing technology. Conveniently located just over 40 miles from Chicago O’Hare (ORD) International Airport, the facility houses over 30 BFS filling suites for complex ophthalmic drug product preparations. Through our robust network, we offer a variety of complementary services including formulation, API micronization, analytical testing, and clinical supply services to help customers bring their biologic or small molecule from development through commercial production.
Learn more at www.catalent.com
The team at HTL is a very experienced and energetic group inspired by all that can be accomplished by teaming up with clients for ground-breaking histology and IHC (immunohistochemistry) data! We have a great team of high-level scientists at the bench and they work very closely with our boarded pathologists, the image analysis group and the sponsors, to be sure our approach to each project includes the thought and consideration needed to successfully advance their programs through the pipeline.
Learn more at www.histotoxlabs.com
Rose Verhoeven is a drug development professional with expertise in the areas of nonclinical pharmacology, pharmacokinetics, toxicology, and medical writing, with a special emphasis on ophthalmic drug products and drug delivery systems. Little Creek Research is focused on helping small pharma and biotech companies with creation and execution of rigorous and efficient nonclinical development plans, as well as production of high quality regulatory and scientific writing documents to support development programs from pre-IND to NDA.
Learn more at www.littlecreekresearch.com
With decades of successful product development experience, Gary D. Novack, Ph.D., president and founder of PharmaLogic Development, Inc., can help you develop a strategic plan for your product. Once planned, he and his team of experts can help you execute that plan. Working in manifold therapeutic areas with pharmaceuticals, biologics and devices, the firm’s particular expertise is in local therapy (ophthalmology and dermatology).
Learn more at www.pharmalogic.com
Phoenix Technology Group™ empowers people to see. Our technology helps in the fight to prevent blindness by providing clinicians and researchers around the world with stunning retinal images, coupled with timely and accurate retinal data. Founded by Bert Massie, Ph.D., inventor of the first digital camera for pediatric retinal imaging, our company created the Phoenix MICRON™ platform for in-vivo imaging of animals in eye research. Phoenix MICRON™ offers researchers all the most essential modalities they need in a single retinal imaging platform. That’s why Phoenix MICRON™ is the standard of excellence for researchers worldwide; ten of the top twelve research institutions employ one of our solutions.
Learn more at www.phoenixreslabs.com
Trial Runners is a global, niche ophthalmology CRO shaping the future of clinical trials to help others see the world. Founded in 2006, Trial Runners has worked as a partner on over 70 trials and helped over 10,000 patients on the mission to help improve the quality of life of those suffering from ophthalmology-related conditions around the globe. With offices in North Dakota, Texas, Switzerland, and Australia, Trial Runners is ready and able to work on any ophthalmology trial, anywhere in the world. Utilizing customized strategies, Trial Runners is able to help the pharmaceutical community by providing unique value, innovation, and expertise. Our differentiator is our exceptional team of experts, ready to help our biotechnology and pharmaceutical partners bring their life-improving drugs, devices, and therapies to market.
Learn more at www.trialrunners.com